【要闻】印度监管机构批准拜耳与孟山都的交易-仲见尚易邮箱
欲获取更多反垄断与竞争法前沿咨询、评论少年卫斯理 ，请点击蓝字关注公众号
◆ ◆ ◆◆
印度反垄断监管机构已批准拜耳公司收购美国种子巨头孟山都公司，该决定将这笔价值625亿美元的交易推向接近终点西伯利亚鼯鼠 。
德国巨头拜耳公司准备在本季度完成收购，将控制全球25％以上的种子和农药市场。
拜耳公司和孟山都公司在印度都设有子公司，因此他们必须从印度竞争委员会（CCI）获得许可。
CCI在Twitter上表示乌山云雨，这项收购已经获得批准，“但须进行一些调整”。
直接了解此事的消息人士称卡延塔 ，CCI的许可是该交易最后面临的反垄断障碍之一。
CCI尚未公布所附加的条件修神传 ，但消息来源称，监管机构已要求剥离拜耳的农业种子、蔬菜种子、草铵膦和数字农业业务神仙奶奶 。
拜耳在周二的一份声明中表示简随云 ，在印度的获批是其全球收购的“又一个里程碑”此地别燕丹。
India's antitrust regulator has approved the acquisition of U.S. seed major Monsanto Co by Bayer AG疯狂修复, in a decision that moves the $62.5 billion deal a step closer to the finish line.
German conglomerate Bayer is preparing to close the takeover this quarter, giving it control of more than 25 percent of the world’s seed and pesticides market.
Both Bayer and Monsanto had subsidiaries in India,陆雨棠 making it mandatory for them to receive clearance from the Competition Commission of India (CCI).
The acquisition had been approved “subject to compliance of certain modifications威固v70,” the CCI said on Twitter.
A source with direct knowledge of the matter said CCI’s clearance was among the last antitrust hurdles for the deal.
The CCI hasn’t yet made public the conditions imposed邪御天骄 , but the source said the watchdog had asked for divestment of Bayer’s agriculture seeds步步莲华 , vegetable seeds花月婷 , glufosinate-ammonium and the digital agriculture business.
In a statement on Tuesday犍为天气预报 , Bayer said the Indian clearance was “another milestone” towards the global acquisition.
来源/Source：Reuters
欢迎关注
更多反垄断资讯
尽在“仲见”
